pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
BCMA · news · pharmadog
← back to BCMA
News · BCMA
13
stories
8h
Genentech doubles down on ADC-resistant cancers with $1B DualityBio pact
fiercebiotech
10d
Regeneron ends eye disease trial for anti-CD3 antibody following safety review
fiercebiotech
14d
After 2 undisclosed gene therapy deaths, can China’s alternative regulatory path still be trusted?
fiercebiotech
16d
Boulevard starts up with $65M to pursue targeted autoimmune drugs
biopharma dive
16d
Deerfield-backed Boulevard Bio embarks on ‘beautiful path to a cure’ with trio of immunology drugs
fiercebiotech
25d
Editor’s Corner: Why an AstraZeneca-Bristol Myers Squibb merger is a bad idea
fiercebiotech
Jul 27, 26
Lilly, AbbVie climb aboard in vivo CAR T train—but safety remains a hurdle
biospace
Jul 16, 26
‘Substantially better than before’: Why India has golden opportunity to build on innovative R&D wins
fiercebiotech
May 14, 26
Create Medicines raises $122M to bolster in vivo CAR-T therapies
biopharma dive
May 6, 26
Consensus Viewpoints Offer Guidance in Rapidly Evolving Multiple Myeloma Management
onclive
May 4, 26
UCB to acquire maker of antibody treatments for autoimmune diseases
stat
May 4, 26
UCB to acquire Candid in $2.2B bet on bispecifics for autoimmune diseases
biopharma dive
Dec 22, 25
Fierce Biotech Fundraising Tracker '26: Abcuro secures $66M; InduPro assembles $77M
fiercebiotech
